Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial is a research paper published in Endocrine Related Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: U10 CA037429
Intramural NIH HHS
Grant: Z01 BC010453
NCI NIH HHS
Grant: P01 CA108964
NCI NIH HHS
Grant: UM1 CA182883
NCI NIH HHS
Grant: U01 CA182883
NCI NIH HHS
Grant: UG1 CA189974
Intramural NIH HHS
Grant: ZIA BC010453
National Institutes of Health
Grant: 3UM1CA182883-05S1
Enhancing the PCPT/SELECT cohorts Core Infrastructure Grant to support studies evaluating dietary supplement use and disease risk
National Institutes of Health
Grant: 2U10CA037429-04
SOUTHWEST ONCOLOGY GROUP -- CCOP RESARCH BASE
National Institutes of Health
Grant: 5P01CA108964-02
IGF-1Axis and Insulin Resistance in PCPT
National Institutes of Health
Grant: 1Z01BC010453-04
Identify SNPs and Polymorphisms that are Important in th
FWCI
1.30
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals